Long non-coding RNA BACE1-AS plays an oncogenic role in hepatocellular carcinoma cells through miR-214-3p/APLN axis. (12th October 2021)

• Record Type: Journal Article
• Authors: Tian, Qing; Yan, Xiaodong; Yang, Long; Liu, Zirong; Yuan, Zheyue; Zhang, Yamin
• Is Part Of: Acta biochimica et biophysica Sinica. Volume 53:Number 11(2021)
• Page Start: 1538
• Page End: 1546
• Publication Date: 2021-10-12
• Subjects: BACE1-AS -- miR-214-3p -- APLN -- proliferation -- cell cycle -- HCC; Biochemistry -- Periodicals; Biophysics -- Periodicals; 572.05
• DOI: 10.1093/abbs/gmab134
• Languages: English
• ISSNs: 1672-9145

Abstract

Abstract: BACE1 antisense RNA (BACE1-AS) is implicated in promoting cell proliferation in different types of tumors. However, the function and mechanism of BACE1-AS in hepatocellular carcinoma (HCC) are still unclear. In the present study, we found that the relative expression of BACE1-AS in HCC cell lines, HCC tissues, and serum samples of HCC patients was significantly increased, and its high expression was correlated with the poor prognosis of HCC patients. In addition, overexpression of BACE1 promoted HCC cell proliferation, cell cycle progression, migration, and invasion, but inhibited cell apoptosis, while knockdown of BACE1 exerted the opposite role. Furthermore, BACE1-AS sponged miR-214-3p and inhibited its expression, thus promoting Apelin (APLN) expression. Overexpression or knockdown of miR-214-3p could partially reverse the abnormal proliferation, cell cycle progression, migration, invasion, and apoptosis caused by overexpression or knockdown of BACE1. These findings suggest that the BACE1-AS/miR-214-3p/APLN axis is a novel signaling pathway that facilitates HCC.